Cancer Blog
- Dr. Robert Nagourney -

Patients never have a second chance to receive first-line therapy, yet first-line therapy offers the best chance of durable remission.  

Even here in the potentially curable pancreatic cancer patients, there is a great deal of disagreement on the best treatment.

Nagourney Cancer Institute remains committed to pioneering research and that promise real hope for those affected by pancreatic cancer.

Screening for Pancreatic cancer, even in the highest-risk individuals found not cost effective.

The incidence of pancreatic cancer in the United States is increasing at an alarming rate. With 57,600 new diagnoses and 47,050 deaths in...